journal article·2024-08Open access

Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome‐lysosome Fusion in NSCLC

Weina Guo, Haifeng Zhou, Jingbo Wang, Junjie Lu, Yalan Dong, Zhenyu Kang, Xiaoyuan Qiu, Xiaohu Ouyang, Qianyun Chen, Junyi Li, Xiang Cheng, Keye Du, Mingyue Li, Zhihao Lin, Min Jin, Lei Zhang, Alexey Sarapultsev, Kuangyu Shi, Fangfei Li, Ge Zhang, Kongming Wu, Yueguang Rong, Vigo Heissmeyer, Yue Liu, Yunlun Li, Kun Huang, Shanshan Luo, Desheng Hu

Advanced Science· Volume 11· Issue 31

Abstract

Abstract Aloperine (ALO), a quinolizidine‐type alkaloid isolated from a natural Chinese herb, has shown promising antitumor effects. Nevertheless, its common mechanism of action and specific target remain elusive. Here, it is demonstrated that ALO inhibits the proliferation and migration of non‐small cell lung cancer cell lines in vitro and the tumor development in several mouse tumor models in vivo. Mechanistically, ALO inhibits the fusion of autophagosomes with lysosomes and the autophagic flux, leading to the accumulation of sequestosome‐1 (SQSTM1) and production of reactive oxygen species (ROS), thereby inducing tumor cell apoptosis and preventing tumor growth. Knockdown of SQSTM1 in cells inhibits ROS production and reverses ALO‐induced cell apoptosis. Furthermore, VPS4A is identified as a direct target of ALO, and the amino acids F153 and D263 of VPS4A are confirmed as the binding sites for ALO. Knockout of VPS4A in H1299 cells demonstrates a similar biological effect as ALO treatment. Additionally, ALO enhances the efficacy of the anti‐PD‐L1/TGF‐β bispecific antibody in inhibiting LLC‐derived subcutaneous tumor models. Thus, ALO is first identified as a novel late‐stage autophagy inhibitor that triggers tumor cell death by targeting VPS4A.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Genomics, phytochemicals, and oxidative stress · Autophagy in Disease and Therapy · Calcium signaling and nucleotide metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Integrated Traditional Chinese and Western Medicine Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Department of Laboratory Medicine Wuhan Children's Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Xiangyang Central Hospital Affiliated Hospital of Hubei University of Arts and Science Xiangyang 441000 China

Hubei Key Laboratory of Biological Targeted Therapy Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China

Department of Neurosurgery Union Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Department of Gastroenterology Zhongda Hospital, Southeast University Nanjing 210000 China

Institute of Neuroscience, School of Medicine Xiamen University Xiamen 361000 China

Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan 250014 China

School of Medical Biology South Ural State University Chelyabinsk 454087 Russia

Department of Nuclear Medicine University of Bern Bern 3007 Switzerland

Shum Yiu Foon Sum Bik Chuen Memorial Centre for Cancer and Inflammation Research School of Chinese Medicine Hong Kong Baptist University Hong Kong SAR 999077 China

Institute of Integrated Bioinfomedicine and Translational Science School of Chinese Medicine Hong Kong Baptist University Hong Kong SAR 999077 China

Department of Oncology Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

School of Basic Medicine of Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Institute for Immunology Biomedical Center Ludwig‐Maximilians‐Universität München 82152 Planegg‐Martinsried Germany

Cardiovascular Disease Center Xiyuan hospital of China academy of Chinese medical Sciences Beijing 100102 China

Innovation Research Institute of Traditional Chinese Medicine Shandong University of Traditional Chinese Medicine Jinan 250355 China

School of Pharmacy of Tongji Medical College Huazhong University of Science and Technology Wuhan 430030 China

Institute of Hematology, Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Hubei Key Laboratory of Biological Targeted Therapy China‐Russia Medical Research Center for Stress Immunology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Funding

National Natural Science Foundation of China

References (62)

Show source-provided references
1. 10.3389/fonc.2022.86195910.3389/fonc.2022.861959 ↗
2. 10.1016/j.arr.2018.08.00410.1016/j.arr.2018.08.004 ↗
3. 10.1101/gad.201621110.1101/gad.2016211 ↗
4. 10.1016/j.ctarc.2019.10015810.1016/j.ctarc.2019.100158 ↗
5. 10.1038/s41580-019-0177-410.1038/s41580-019-0177-4 ↗
6. 10.1016/j.bbamcr.2011.08.01710.1016/j.bbamcr.2011.08.017 ↗
7. 10.1038/cdd.2014.15010.1038/cdd.2014.150 ↗
8. 10.1016/j.cub.2007.09.03210.1016/j.cub.2007.09.032 ↗
9. 10.1016/j.cell.2017.07.00510.1016/j.cell.2017.07.005 ↗
10. 10.1053/j.seminoncol.2021.05.00210.1053/j.seminoncol.2021.05.002 ↗
11. 10.1007/978-3-030-42667-5_110.1007/978-3-030-42667-5_1 ↗
12. 10.1016/S0070-2153(06)78006-110.1016/S0070-2153(06)78006-1 ↗
13. 10.1128/MCB.25.3.1025-1040.200510.1128/MCB.25.3.1025-1040.2005 ↗
14. 10.3892/ijmm.2014.171810.3892/ijmm.2014.1718 ↗
15. 10.1186/s13045-015-0120-x10.1186/s13045-015-0120-x ↗
16. Lee Y. R. · Int. J. Mol. Sci. · 2018 · 19
17. 10.1016/j.cmet.2017.04.00410.1016/j.cmet.2017.04.004 ↗
18. 10.1080/15548627.2020.173127010.1080/15548627.2020.1731270 ↗
19. 10.1089/ars.2018.764910.1089/ars.2018.7649 ↗
20. 10.1080/15548627.2018.151150310.1080/15548627.2018.1511503 ↗
21. 10.1080/15548627.2015.101718510.1080/15548627.2015.1017185 ↗
22. 10.1038/s41422-019-0164-510.1038/s41422-019-0164-5 ↗
23. 10.1172/JCI6449810.1172/JCI64498 ↗
24. 10.1016/j.bbamcr.2016.09.01210.1016/j.bbamcr.2016.09.012 ↗
25. 10.4161/cbt.7.12.706710.4161/cbt.7.12.7067 ↗
26. 10.1083/jcb.20070211510.1083/jcb.200702115 ↗
27. 10.1038/s41467-022-29412-310.1038/s41467-022-29412-3 ↗
28. 10.1126/science.abl385510.1126/science.abl3855 ↗
29. 10.1002/JLB.MR0718-269R10.1002/JLB.MR0718-269R ↗
30. 10.1186/s13045-021-01155-610.1186/s13045-021-01155-6 ↗
31. 10.1038/s41419-022-04808-710.1038/s41419-022-04808-7 ↗
32. 10.1111/1759-7714.1390410.1111/1759-7714.13904 ↗
33. 10.1186/s13046-019-1093-310.1186/s13046-019-1093-3 ↗
34. 10.1007/s00280-016-3197-110.1007/s00280-016-3197-1 ↗
35. Yu H. I. · Int. J. Mol. Sci. · 2019 · 20
36. 10.1007/s00432-020-03157-210.1007/s00432-020-03157-2 ↗
37. 10.1016/j.toxicon.2020.03.01210.1016/j.toxicon.2020.03.012 ↗
38. 10.4161/auto.2803410.4161/auto.28034 ↗
39. 10.1080/15548627.2015.105697010.1080/15548627.2015.1056970 ↗
40. 10.1016/j.semcdb.2017.05.02310.1016/j.semcdb.2017.05.023 ↗
41. 10.4161/auto.6.7.1211310.4161/auto.6.7.12113 ↗
42. 10.1016/j.tcb.2006.04.00410.1016/j.tcb.2006.04.004 ↗
43. 10.1016/j.freeradbiomed.2013.11.01010.1016/j.freeradbiomed.2013.11.010 ↗
44. 10.1038/ncb202110.1038/ncb2021 ↗
45. 10.1111/j.1742-7843.2010.00653.x10.1111/j.1742-7843.2010.00653.x ↗
46. 10.1159/00050076110.1159/000500761 ↗
47. 10.3892/etm.2021.1047810.3892/etm.2021.10478 ↗
48. 10.1155/2017/570615210.1155/2017/5706152 ↗
49. 10.1038/s41598-018-24565-y10.1038/s41598-018-24565-y ↗
50. 10.2119/molmed.2015.0005610.2119/molmed.2015.00056 ↗
51. 10.1016/j.ejphar.2021.17472110.1016/j.ejphar.2021.174721 ↗
52. Dong L. · Pharmaceuticals · 2023 · 16
53. 10.1039/C8FO01137K10.1039/C8FO01137K ↗
54. 10.1021/acs.jafc.8b0402010.1021/acs.jafc.8b04020 ↗
55. 10.7150/thno.3037210.7150/thno.30372 ↗
56. 10.1016/j.jhazmat.2015.10.04110.1016/j.jhazmat.2015.10.041 ↗
57. 10.1080/15548627.2020.184195310.1080/15548627.2020.1841953 ↗
58. 10.1016/j.cell.2018.02.05210.1016/j.cell.2018.02.052 ↗
59. 10.1038/s41467-019-13528-010.1038/s41467-019-13528-0 ↗
60. 10.1096/fj.201802659RR10.1096/fj.201802659RR ↗
61. 10.1186/1479-5876-9-5110.1186/1479-5876-9-51 ↗
62. 10.1016/j.vaccine.2011.07.07010.1016/j.vaccine.2011.07.070 ↗